Literature DB >> 31652923

Glutamine Metabolism in Brain Tumors.

Siva Kumar Natarajan1, Sriram Venneti2,3.   

Abstract

Altered metabolism is a hallmark of cancer cells. Tumor cells rewire their metabolism to support their uncontrolled proliferation by taking up nutrients from the microenvironment. The amino acid glutamine is a key nutrient that fuels biosynthetic processes including ATP generation, redox homeostasis, nucleotide, protein, and lipid synthesis. Glutamine as a precursor for the neurotransmitter glutamate, and plays a critical role in the normal functioning of the brain. Brain tumors that grow in this glutamine/glutamate rich microenvironment can make synaptic connections with glutamatergic neurons and reprogram glutamine metabolism to enable their growth. In this review, we examine the functions of glutamate/glutamine in the brain and how brain tumor cells reprogram glutamine metabolism. Altered glutamine metabolism can be leveraged to develop non-invasive imaging strategies and we review these imaging modalities. Finally, we examine if targeting glutamine metabolism could serve as a therapeutic strategy in brain tumors.

Entities:  

Keywords:  brain tumor; glutamate; glutamine; imaging; metabolism; redox homeostasis; therapy

Year:  2019        PMID: 31652923     DOI: 10.3390/cancers11111628

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  13 in total

1.  Signal enhancement of glutamine and glutathione by single-step spectral editing.

Authors:  Li An; Maria Ferraris Araneta; Milalynn Victorino; Jun Shen
Journal:  J Magn Reson       Date:  2020-06-01       Impact factor: 2.229

2.  CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells.

Authors:  Elham Poonaki; Ann-Christin Nickel; Mehdi Shafiee Ardestani; Lars Rademacher; Marilyn Kaul; Evgeny Apartsin; Sven G Meuth; Ali Gorji; Christoph Janiak; Ulf Dietrich Kahlert
Journal:  Int J Mol Sci       Date:  2022-05-13       Impact factor: 6.208

Review 3.  Flexibility and Adaptation of Cancer Cells in a Heterogenous Metabolic Microenvironment.

Authors:  Gabriele Grasmann; Ayusi Mondal; Katharina Leithner
Journal:  Int J Mol Sci       Date:  2021-02-02       Impact factor: 5.923

Review 4.  MR-Guided Radiotherapy for Brain and Spine Tumors.

Authors:  Danilo Maziero; Michael W Straza; John C Ford; Joseph A Bovi; Tejan Diwanji; Radka Stoyanova; Eric S Paulson; Eric A Mellon
Journal:  Front Oncol       Date:  2021-03-08       Impact factor: 6.244

Review 5.  Emerging MR Imaging and Spectroscopic Methods to Study Brain Tumor Metabolism.

Authors:  Manoj Kumar; Ravi Prakash Reddy Nanga; Gaurav Verma; Neil Wilson; Jean Christophe Brisset; Kavindra Nath; Sanjeev Chawla
Journal:  Front Neurol       Date:  2022-03-16       Impact factor: 4.003

Review 6.  Metabolic Drivers of Invasion in Glioblastoma.

Authors:  Joseph H Garcia; Saket Jain; Manish K Aghi
Journal:  Front Cell Dev Biol       Date:  2021-07-01

Review 7.  Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma.

Authors:  Wanqing Weng; Zhongjing Zhang; Weiguo Huang; Xiangxiang Xu; Boda Wu; Tingbo Ye; Yunfeng Shan; Keqing Shi; Zhuo Lin
Journal:  Cancer Cell Int       Date:  2020-06-11       Impact factor: 5.722

Review 8.  The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment.

Authors:  Yajing Mi; Na Guo; Jing Luan; Jianghong Cheng; Zhifang Hu; Pengtao Jiang; Weilin Jin; Xingchun Gao
Journal:  Front Immunol       Date:  2020-04-24       Impact factor: 7.561

9.  Metabolic Reprogramming and Vulnerabilities in Cancer.

Authors:  Costas A Lyssiotis; Deepak Nagrath
Journal:  Cancers (Basel)       Date:  2019-12-30       Impact factor: 6.639

Review 10.  Take Advantage of Glutamine Anaplerosis, the Kernel of the Metabolic Rewiring in Malignant Gliomas.

Authors:  Filipa Martins; Luís G Gonçalves; Marta Pojo; Jacinta Serpa
Journal:  Biomolecules       Date:  2020-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.